New obesity drug aims for gentler dose ramp-up
NCT ID NCT06718998
First seen Nov 01, 2025 · Last updated Jun 05, 2026 · Updated 26 times
Summary
This early study tested a new medicine called NNC0519-0130 in 134 adults with overweight or obesity. Researchers compared four different ways of increasing the dose over time to see which caused fewer side effects. The study lasted about 24 weeks and focused on safety and tolerability.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of Graz
Graz, 8010, Austria
Conditions
Explore the condition pages connected to this study.